| $337M | ||
| $259M | ||
| $79M | ||
| $60M | ||
| $58M | ||
| $50M |
Buys | $17,285,082 | 14 | 100 |
Sells | $0 | 0 | 0 |
| BROADWOOD PARTNERS, L.P. | 10 percent owner | 2 | $14.47M | 0 | $0 | $14.47M |
| SMITH PATRICK W | 10 percent owner | 8 | $2.45M | 0 | $0 | $2.45M |
| James Andrea S. | Chief Financial Officer | 3 | $345,800 | 0 | $0 | $345,800 |
| Arno Andrew | director | 1 | $26,350 | 0 | $0 | $26,350 |
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing, assay design and development, and clinical trial support services, as well as various biomarker tests for pharmaceutical companies. The company has a collaboration agreement with Life Technologies Corporation to develop and collaborate in the commercialization of Oncomine Comprehensive Assay Plus and Determa IO assay for use with Ion Torrent Genexus integrated sequencer and purification system. OncoCyte Corporation was incorporated in 2009 and is based in Irvine, California.
Over the last 12 months, insiders at OncoCyte Corporation have bought $17.29M and sold $0 worth of OncoCyte Corporation stock.
On average, over the past 5 years, insiders at OncoCyte Corporation have bought $14.24M and sold $49,201 worth of stock each year.
Highest buying activity among insiders over the last 12 months: BROADWOOD PARTNERS, L.P. (10 percent owner) — $14.47M. SMITH PATRICK W (10 percent owner) — $2.45M. James Andrea S. (Chief Financial Officer) — $345,800.
The last purchase of 1,077,600 shares for transaction amount of $2.21M was made by SMITH PATRICK W (10 percent owner) on 2025‑02‑07.
| 2025-02-07 | SMITH PATRICK W | 10 percent owner | 1.08M 6.4009% | $2.05 | $2.21M | +45.27% | ||
| 2025-02-07 | James Andrea S. | Chief Financial Officer | 97,561 0.5795% | $2.05 | $200,000 | +45.27% | ||
| 2025-02-06 | BROADWOOD PARTNERS, L.P. | 10 percent owner | 5.17M 29.1213% | $2.05 | $10.59M | +42.44% | ||
| 2025-02-04 | SMITH PATRICK W | 10 percent owner | 25 0.0001% | $2.02 | $51 | +37.09% | ||
| 2025-01-31 | SMITH PATRICK W | 10 percent owner | 890 0.0053% | $2.01 | $1,789 | +41.06% | ||
| 2025-01-30 | SMITH PATRICK W | 10 percent owner | 318 0.0019% | $2.01 | $639 | +45.27% | ||
| 2025-01-29 | SMITH PATRICK W | 10 percent owner | 3,880 0.0228% | $2.01 | $7,799 | +44.06% | ||
| 2025-01-14 | SMITH PATRICK W | 10 percent owner | 10,386 0.0608% | $2.15 | $22,323 | +32.67% | ||
| 2025-01-13 | SMITH PATRICK W | 10 percent owner | 5,669 0.0337% | $2.08 | $11,792 | +37.02% | ||
| 2024-12-26 | SMITH PATRICK W | 10 percent owner | 90,219 0.5436% | $2.13 | $192,166 | +32.86% | ||
| 2024-12-26 | Arno Andrew | director | 12,500 0.0745% | $2.11 | $26,350 | +32.86% | ||
| 2024-12-05 | James Andrea S. | Chief Financial Officer | 20,000 0.1168% | $2.29 | $45,800 | +20.00% | ||
| 2024-10-02 | BROADWOOD PARTNERS, L.P. | 10 percent owner | 1.32M 9.7663% | $2.95 | $3.88M | -7.21% | ||
| 2024-10-02 | James Andrea S. | Chief Financial Officer | 33,670 0.2519% | $2.97 | $100,000 | -7.21% | ||
| 2024-04-11 | BROADWOOD PARTNERS, L.P. | 10 percent owner | 2.42M 28.8149% | $2.92 | $7.06M | -3.37% | ||
| 2024-04-11 | Arno Andrew | director | 33,898 0.4083% | $2.95 | $99,999 | -3.37% | ||
| 2024-04-11 | Riggs Josh | CEO and President | 3,390 0.0408% | $2.95 | $10,001 | -3.37% | ||
| 2023-06-14 | KINGSLEY ALFRED D | director | 30,000 0.0246% | $0.21 | $6,447 | -30.23% | ||
| 2023-04-05 | PURA VIDA INVESTMENTS, LLC | 10 percent owner | 663,000 0.6681% | $0.30 | $200,027 | -37.78% | ||
| 2023-04-03 | BROADWOOD PARTNERS, L.P. | 10 percent owner | 26.83M 23.0078% | $0.30 | $8.09M | -47.09% |
| BROADWOOD PARTNERS, L.P. | 10 percent owner | 11410100 39.8964% | $36.51M | 14 | 0 | <0.0001% |
| SMITH PATRICK W | 10 percent owner | 2872671 10.0446% | $9.19M | 8 | 0 | |
| James Andrea S. | Chief Financial Officer | 151231 0.5288% | $483,939.20 | 3 | 0 | |
| Arno Andrew | director | 81554 0.2852% | $260,972.80 | 7 | 0 | <0.0001% |
| BROADWOOD CAPITAL INC | 23353697 81.6583% | $74.73M | 1 | 0 | <0.0001% | |
| Kamen Efrem | 8520146 29.7914% | $27.26M | 1 | 1 | <0.0001% | |
| PURA VIDA INVESTMENTS, LLC | 10 percent owner | 8090202 28.2881% | $25.89M | 2 | 0 | <0.0001% |
| Lineage Cell Therapeutics, Inc. | 6041154 21.1234% | $19.33M | 0 | 3 | ||
| KINGSLEY ALFRED D | director | 469111 1.6403% | $1.5M | 3 | 3 | <0.0001% |
| ANDREWS RONALD ASBURY | President & CEO | 333212 1.1651% | $1.07M | 8 | 0 | +3.75% |
| Redmond Cavan M. | 110863 0.3876% | $354,761.60 | 2 | 0 | <0.0001% | |
| Levine Mitchell S | Chief Financial Officer | 87080 0.3045% | $278,656.00 | 5 | 0 | +111.03% |
| Gutfreund John Peter | director | 75000 0.2622% | $240,000.00 | 2 | 0 | <0.0001% |
| Last Andrew J. | 70170 0.2454% | $224,544.00 | 2 | 0 | <0.0001% | |
| Carter Jennifer L. | 30500 0.1066% | $97,600.00 | 1 | 0 | <0.0001% | |
| GRIFFITH MELINDA | 30000 0.1049% | $96,000.00 | 1 | 0 | <0.0001% | |
| Ross Douglas T. | Chief Scientific Officer | 20317 0.071% | $65,014.40 | 1 | 0 | <0.0001% |
| Yu Li | VP Cntrllr/Prncpl Acctng Offcr | 16872 0.059% | $53,990.40 | 0 | 1 | |
| Paulsen Gisela | Chief Operating Officer | 16500 0.0577% | $52,800.00 | 2 | 0 | <0.0001% |
| KALAJIAN TONY T | Sr.VP/Chief Accounting Officer | 15000 0.0524% | $48,000.00 | 2 | 0 | +163.52% |
| Parker Albert P | Chief Operating Officer | 5000 0.0175% | $16,000.00 | 1 | 0 | +163.52% |
| Riggs Josh | CEO and President | 3505 0.0123% | $11,216.00 | 1 | 0 | <0.0001% |
| ANNETT WILLIAM | President and CEO | 3500 0.0122% | $11,200.00 | 1 | 0 | |
| HESTERBERG LYNDAL K. | Sr VP, Research & Development | 874 0.0031% | $2,796.80 | 1 | 0 |
$30,470,407 | 140 | 20.39% | $100M | |
$2,611,792 | 112 | 12.56% | $88.54M | |
$49,091,668 | 110 | 13.11% | $101.69M | |
$679,720 | 45 | -16.13% | $91.52M | |
OncoCyte Corporation (OCX) | $53,912,175 | 35 | -8.02% | $91.52M |
$7,147,964 | 34 | 24.78% | $87.83M | |
$18,752,549 | 33 | -28.39% | $99.68M | |
$64,487,106 | 32 | -22.92% | $89.31M | |
$40,617,659 | 23 | 2.15% | $86.43M | |
$111,692,551 | 18 | 13.51% | $94.1M | |
$277,862 | 15 | 59.79% | $90.45M | |
$73,968,137 | 12 | -34.52% | $85.65M | |
$135,589,307 | 10 | 32.46% | $99.29M | |
$13,919,584 | 9 | -30.43% | $91.96M | |
$13,043,783 | 8 | 732.82% | $87.79M | |
$30,149,552 | 3 | -66.74% | $94.27M | |
$16,003,671 | 3 | 55.38% | $88.99M | |
$4,030 | 1 | 9.14% | $86.89M | |
$3,620 | 1 | 94.16% | $92.15M |
| Increased Positions | 17 | +62.96% | 8M | +91.72% |
| Decreased Positions | 10 | -37.04% | 42,041 | -0.5% |
| New Positions | 8 | New | 134,306 | New |
| Sold Out Positions | 4 | Sold Out | 25,528 | Sold Out |
| Total Postitions | 34 | +25.93% | 16M | +91.22% |
| Broadwood Capital Inc | $18,889.00 | 21.53% | 6.24M | +1M | +26.68% | 2024-12-31 |
| Awm Investment Company, Inc. | $2,347.00 | 2.68% | 775,804 | -321,371 | -29.29% | 2024-12-31 |
| Pura Vida Investments, Llc | $1,980.00 | 2.26% | 654,451 | +159,106 | +32.12% | 2024-12-31 |
| Vanguard Group Inc | $733.00 | 0.84% | 242,206 | -3,182 | -1.3% | 2024-12-31 |
| Geode Capital Management, Llc | $415.00 | 0.47% | 137,069 | +33,089 | +31.82% | 2024-12-31 |
| Blackrock, Inc. | $241.00 | 0.27% | 79,585 | -372 | -0.47% | 2025-03-31 |
| Morgan Stanley | $187.00 | 0.21% | 61,708 | -10,581 | -14.64% | 2024-12-31 |
| Wealthedge Investment Advisors, Llc | $160.00 | 0.18% | 52,732 | +52,732 | New | 2024-12-31 |
| Defender Capital, Llc. | $134.00 | 0.15% | 44,378 | -2,700 | -5.74% | 2025-03-31 |
| Fny Investment Advisers, Llc | $118.00 | 0.14% | 39,172 | -10,205 | -20.67% | 2025-03-31 |